gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection

doi:10.1016/J.VIROL.2005.1

Title: gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection

Full Record
Similar

Abstract

Chimpanzee is a unique animal model for HCV infection, in which about 50% of infections resolve spontaneously. It has been reported that the magnitude of T cell responses to HCV core in recovered chimpanzees is greater than that in chronically infected ones. However, the mechanism(s) by which the chimpanzees with resolved infection overcome core-mediated immunosuppression remains unknown. In this study, we examined the effect of HCV core on T cell responsiveness in chimpanzees with resolved and chronic HCV infection. We found that core protein strongly inhibited T cell activation and proliferation in chimpanzees with chronic infection, while this inhibition was limited in chimpanzees with resolved infection. Notably, the level of gC1qR, as well as the binding of core protein, on the surface of T cells was lower in recovered chimpanzees when compared to chimpanzees with chronic HCV infection. Intriguingly, the observed differences in gC1qR expression levels and susceptibility to core-induced suppression amongst HCV-chronically infected and recovered chimpanzees were observed prior to HCV challenge, suggesting a possible genetic determination of the outcome of infection. These findings suggest that gC1qR expression on the surface of T cells is crucial for HCV core-mediated T cell suppression and viral clearance, and that represents amore »« less

Authors:

Yao Zhiqang ^[1]; Shata, Mohamed Tarek ^[2]; Tricoche, Nancy ^[3]; Shan, M.M. ^[3]; Brotman, Betsy ^[3]; Pfahler, Wolfram ^[3]; Hahn, Young S. ^[4]; Prince, Alfred M. ^[3]

Department of Microbiology and Pathology, Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908 (United States)
Viral Immunology Laboratory, Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati Medical Center Cincinnati, OH 45267 (United States)
Laboratory of Virology, Lindsley F. Kimball Research Institute, New York Blood Center, NY 10021 (United States)
Department of Microbiology and Pathology, Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908 (United States). E-mail: ysh5e@virginia.edu

Publication Date:: Wed Mar 15 00:00:00 EST 2006

OSTI Identifier:: 20779467

Resource Type:: Journal Article

Resource Relation:: Journal Name: Virology; Journal Volume: 346; Journal Issue: 2; Other Information: DOI: 10.1016/j.virol.2005.11.020; PII: S0042-6822(05)00768-3; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES; CELL PROLIFERATION; IMMUNOSUPPRESSION; INHIBITION; PROTEINS; VIRUSES

Citation Formats


                    Yao Zhiqang, Shata, Mohamed Tarek, Tricoche, Nancy, Shan, M.M., Brotman, Betsy, Pfahler, Wolfram, Hahn, Young S., and Prince, Alfred M.. gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.  United States: N. p., 2006. 
        Web.  doi:10.1016/J.VIROL.2005.1.

Copy to clipboard


                    Yao Zhiqang, Shata, Mohamed Tarek, Tricoche, Nancy, Shan, M.M., Brotman, Betsy, Pfahler, Wolfram, Hahn, Young S., & Prince, Alfred M.. gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.  United States.  doi:10.1016/J.VIROL.2005.1.

Copy to clipboard


                    Yao Zhiqang, Shata, Mohamed Tarek, Tricoche, Nancy, Shan, M.M., Brotman, Betsy, Pfahler, Wolfram, Hahn, Young S., and Prince, Alfred M.. Wed .  
        "gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection".  United States.  
        doi:10.1016/J.VIROL.2005.1.

Copy to clipboard


                    
@article{osti_20779467,

  title        = {gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection},

  author       = {Yao Zhiqang and Shata, Mohamed Tarek and Tricoche, Nancy and Shan, M.M. and Brotman, Betsy and Pfahler, Wolfram and Hahn, Young S. and Prince, Alfred M.},

  abstractNote = {Chimpanzee is a unique animal model for HCV infection, in which about 50% of infections resolve spontaneously. It has been reported that the magnitude of T cell responses to HCV core in recovered chimpanzees is greater than that in chronically infected ones. However, the mechanism(s) by which the chimpanzees with resolved infection overcome core-mediated immunosuppression remains unknown. In this study, we examined the effect of HCV core on T cell responsiveness in chimpanzees with resolved and chronic HCV infection. We found that core protein strongly inhibited T cell activation and proliferation in chimpanzees with chronic infection, while this inhibition was limited in chimpanzees with resolved infection. Notably, the level of gC1qR, as well as the binding of core protein, on the surface of T cells was lower in recovered chimpanzees when compared to chimpanzees with chronic HCV infection. Intriguingly, the observed differences in gC1qR expression levels and susceptibility to core-induced suppression amongst HCV-chronically infected and recovered chimpanzees were observed prior to HCV challenge, suggesting a possible genetic determination of the outcome of infection. These findings suggest that gC1qR expression on the surface of T cells is crucial for HCV core-mediated T cell suppression and viral clearance, and that represents a novel mechanism by which a virus usurps host machinery for persistence.},

  doi          = {10.1016/J.VIROL.2005.1},

  journal      = {Virology},

  number       = 2,

  volume       = 346,

  place        = {United States},

  year         = {Wed Mar 15 00:00:00 EST 2006},

  month        = {Wed Mar 15 00:00:00 EST 2006}

}

Copy to clipboard

Journal Article:

DOI: 10.1016/J.VIROL.2005.1

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein

Al Olaby, Reem R. ; Cocquerel, Laurence ; Zemla, Adam ; ... - PLoS ONE

We report that Hepatitis C Virus (HCV) infects 200 million individuals worldwide. Although several FDA approved drugs targeting the HCV serine protease and polymerase have shown promising results, there is a need for better drugs that are effective in treating a broader range of HCV genotypes and subtypes without being used in combination with interferon and/or ribavirin. Recently, two crystal structures of the core of the HCV E2 protein (E2c) have been determined, providing structural information that can now be used to target the E2 protein and develop drugs that disrupt the early stages of HCV infection by blocking E2’smore »« less
Cited by 8
DOI: 10.1371/journal.pone.0111333

Full Text Available
A hantavirus causing hemorrhagic fever with renal syndrome requires gC1qR/p32 for efficient cell binding and infection

Choi, Yun ; Kwon, Young-Chan ; Kim, Soo-In ; ... - Virology

Hantaan virus (HTNV) is a pathogenic hantavirus that causes hemorrhagic fever with renal syndrome (HFRS). HTNV infection is mediated by {alpha}v{beta}3 integrin. We used protein blots of Vero E6 cell homogenates to demonstrate that radiolabeled HTNV virions bind to gC1qR/p32, the acidic 32-kDa protein known as the receptor for the globular head domain of complement C1q. RNAi-mediated suppression of gC1qR/p32 markedly reduced HTNV binding and infection in human lung epithelial A549 cells. Conversely, transient expression of either simian or human gC1qR/p32 rendered non-permissive CHO cells susceptible to HTNV infection. These results suggest an important role for gC1qR/p32 in HTNV infectionmore » and pathogenesis.« less
DOI: 10.1016/j.virol.2008.08.035
Glycosylation of the T-cell antigen-specific receptor and its potential role in lectin-mediated cytotoxicity

Hubbard, S.C. ; Kranz, D.M. ; Longmore, G.D. ; ... - Proc. Natl. Acad. Sci. U.S.A.; (United States)

Cytotoxic T lymphocytes (CTLs) normally destroy only those cells (target cells) whose surface antigens they recognize. However, in the presence of lectins such as Con A, CTLs destroy virtually any cell, regardless of its antigens. The oligosaccharides of the T-cell antigen-specific receptor, a dimeric surface glycoprotein composed of disulfide-linked ..cap alpha.. and ..beta.. subunits, are of interest because of their potential involvement in this lectin-dependent cytotoxic activity. The authors report here that three or four asparagine-linked oligosaccharides could be enzymatically removed from each of the receptor subunits expressed by a cloned line of murine CTLs (clone 2C), consistent with themore »« less
DOI: 10.1073/pnas.83.6.1852
Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV{sub KU2} infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail

Nehete, Pramod N. ; Nehete, Bharti P. ; Hill, Lori ; ... - Virology

Infection of Indian-origin rhesus macaques by the simian human immunodeficiency virus (SHIV) is considered to be a suitable preclinical model for directly testing efficacy of vaccine candidates based on the HIV-1 envelope. We used this model for prophylactic vaccination with a peptide-cocktail comprised of highly conserved HIV-1 envelope sequences immunogenic/antigenic in macaques and humans. Separate groups of macaques were immunized with the peptide-cocktail by intravenous and subcutaneous routes using autologous dendritic cells (DC) and Freund's adjuvant, respectively. The vaccine elicited antigen specific IFN-{gamma}-producing cells and T-cell proliferation, but not HIV-neutralizing antibodies. The vaccinated animals also exhibited efficient cross-clade cytolytic activitymore »« less
DOI: 10.1016/j.virol.2007.08.022
Effect of interferon therapy on radionuclide imaging in chronic liver diseases due to HCV infection

Ghaffar, Y. ; Dorgham, L. ; Lotfy, N. - Journal of Nuclear Medicine

Interferon (alpha-IFN) exerts a modulating effect on the immune system. Kupffer cells of the liver play an important immunological role by their uptake of various agents and particles, including colloids. We sought to discover if alpha-IFN could enhance the colloid uptake function of the Kupffer cells. The effect of alpha-IFN therapy on radioisotope scans of the liver was studied in 20 patients with chronic liver disease due to hepatitic C virus (HCV) infection who received therapy at a dose of 3 million IU for 6 mo, in another patients who received the same therapy for 12 mo and in matchedmore »« less